153 items

NIH researchers discover tooth-enamel protein in eyes with dry AMD

March 13, 2020

A protein that normally deposits mineralized calcium in tooth enamel may also be responsible for calcium deposits in the back of the eye in people with dry age-related macular degeneration (AMD).

Four in 10 US Adults Are at High Risk for Vision Loss

March 12, 2020

In 2017, approximately 93 million US adults aged 18 years or older, or about 4 in 10, were at high risk for vision loss, according to a new study published in JAMA Ophthalmology.

AI may help spot newborns at risk for most severe form of blinding disease

March 4, 2020

An artificial intelligence (AI) device that has been fast-tracked for approval by the Food and Drug Administration may help identify newborns at risk for aggressive posterior retinopathy of prematurity (AP-ROP). AP-ROP is the most severe form of ROP.

NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace and repair dying cells in retina

December 16, 2019

Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy, the advanced “dry” form of age-related macular degeneration.

NEI seeks public comment on future research goals

December 6, 2019

As the year 2020 approaches, the National Eye Institute (NEI) is developing new plans for vision research over the coming decade.

Treatment for common vision disorder does not improve children’s reading skills

October 23, 2019

Results from a clinical trial funded by the National Eye Institute (NEI) show that while vision therapy can successfully treat convergence insufficiency (CI) in children, it fails to improve their reading test scores.

Two commonly used uveitis drugs perform similarly in NIH-funded clinical trial

September 10, 2019

Methotrexate and the more expensive mycophenolate mofetil performed similarly in a head-to-head clinical trial that compared the two drugs for treating noninfectious uveitis, an eye disease that accounts for up to 15% of blindness in the U. S.

Report: Dry AMD requires broad, systems biology approach leveraging big data, multiple disciplines

July 26, 2019

A large-scale, collaborative, systems biology approach is needed to expedite the discovery of treatments for dry age-related macular degeneration (AMD) – a leading cause of blindness among people 65 and older for which is there is no treatment...

NEI Researchers Awarded Grants by the Knights Templar Eye Foundation

July 11, 2019

The Knights Templar Eye Foundation has awarded two NEI scientists grants to research inherited retinal degenerations, diseases that can cause blindness in early childhood.

Rosy Health and Sickly Green: Color Associations Play Robust Role in Reading Faces

July 8, 2019

Anyone who has ever sensed that a person is sick simply by looking at their face has experienced the wealth of information conveyed by face color.